Scientists at Zirus are working on a new technology platform to cure and manage viral infection through the development of new classes of antivirotics. This animation depicts the life cycle of H1N1 influenza-A virus and the methodology Zirus uses to find appropriate targets.

Watch the NPR featured story on Zirus Antivirotics by Robert Krulwich.

“The best things about working with XVIVO is probably the final product, that is never disappointing but, on the contrary, always beyond expectation. Our clients are happy and so are we. The second best thing is a very good production and revision process thru the web with a reliable schedule. It’s good not to be anxious because you know things will be done in due time (and well done).”
Jean-Pascal Huvé, ScienceProd (Paris, France)